Adverse effects of antiaggregating platelet therapy in the treatment of polycythemia vera - PubMed (original) (raw)
- PMID: 3749927
Adverse effects of antiaggregating platelet therapy in the treatment of polycythemia vera
A P Tartaglia et al. Semin Hematol. 1986 Jul.
No abstract available
Similar articles
- Therapeutic recommendations in polycythemia vera based on Polycythemia Vera Study Group protocols.
Berk PD, Goldberg JD, Donovan PB, Fruchtman SM, Berlin NI, Wasserman LR. Berk PD, et al. Semin Hematol. 1986 Apr;23(2):132-43. Semin Hematol. 1986. PMID: 3704665 Clinical Trial. - Comparison of the effects of acylpyrin, curantyl and ticlid on some platelet functions in patients with polycythemia vera.
Indrák K, Kapustová M, Hrcková Y, Kubis M, Scudla V, Jezdinský J. Indrák K, et al. Acta Univ Palacki Olomuc Fac Med. 1985;111:331-52. Acta Univ Palacki Olomuc Fac Med. 1985. PMID: 2949515 No abstract available. - [Association of polycythemia vera and multiple myeloma. Presentation ofa new case and review of the literature].
Prósper F, Paloma MJ, Rifón J, Cuesta B, Hermida J, Rocha E. Prósper F, et al. Sangre (Barc). 1993 Dec;38(6):497-9. Sangre (Barc). 1993. PMID: 8171387 Review. Spanish. - Neurologic complications of polycythemia and their impact on therapy.
Newton LK. Newton LK. Oncology (Williston Park). 1990 Mar;4(3):59-64; discussion 64-6. Oncology (Williston Park). 1990. PMID: 2144446 Review.
Cited by
- Polycythemia Vera: Barriers to and Strategies for Optimal Management.
Duminuco A, Harrington P, Harrison C, Curto-Garcia N. Duminuco A, et al. Blood Lymphat Cancer. 2023 Dec 21;13:77-90. doi: 10.2147/BLCTT.S409443. eCollection 2023. Blood Lymphat Cancer. 2023. PMID: 38146420 Free PMC article. Review. - Thrombophilia testing: A British Society for Haematology guideline.
Arachchillage DJ, Mackillop L, Chandratheva A, Motawani J, MacCallum P, Laffan M. Arachchillage DJ, et al. Br J Haematol. 2022 Aug;198(3):443-458. doi: 10.1111/bjh.18239. Epub 2022 May 29. Br J Haematol. 2022. PMID: 35645034 Free PMC article. No abstract available. - Polycythemia vera: historical oversights, diagnostic details, and therapeutic views.
Tefferi A, Vannucchi AM, Barbui T. Tefferi A, et al. Leukemia. 2021 Dec;35(12):3339-3351. doi: 10.1038/s41375-021-01401-3. Epub 2021 Sep 3. Leukemia. 2021. PMID: 34480106 Free PMC article. Review. - Evaluation of Therapeutic Strategies to Reduce the Number of Thrombotic Events in Patients With Polycythemia Vera and Essential Thrombocythemia.
Tremblay D, Kosiorek HE, Dueck AC, Hoffman R. Tremblay D, et al. Front Oncol. 2021 Feb 16;10:636675. doi: 10.3389/fonc.2020.636675. eCollection 2020. Front Oncol. 2021. PMID: 33665170 Free PMC article. Review. - Overview of Myeloproliferative Neoplasms: History, Pathogenesis, Diagnostic Criteria, and Complications.
Tremblay D, Yacoub A, Hoffman R. Tremblay D, et al. Hematol Oncol Clin North Am. 2021 Apr;35(2):159-176. doi: 10.1016/j.hoc.2020.12.001. Epub 2021 Jan 26. Hematol Oncol Clin North Am. 2021. PMID: 33641861 Free PMC article. Review.